| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |